India, April 28 -- Indian shares opened on a muted note on Tuesday after it emerged that U.S. President Donald Trump and his national security team are skeptical of Iran's offer of a deal to reopen th... Read More
India, April 28 -- Nestle (Malaysia) Berhad (4707.KL) reported a profit for its first quarter that Increased, from the same period last year The company's bottom line totaled MYR205.12 million, or MY... Read More
India, April 28 -- Airbus SE (EADSY.PK) announced a profit for first quarter that Dropped, from last year The company's earnings totaled EUR586 million, or EUR0.74 per share. This compares with EUR79... Read More
India, April 28 -- Bank of Beijing Co., Ltd. (601169.SS) released a profit for full year that Dropped, from last year The company's earnings totaled RMB20.086 billion, or RMB0.78 per share. This comp... Read More
India, April 28 -- Pfizer Inc. (PFE) on Tuesday said it has reached settlement agreements with Dexcel Pharma, Hikma Pharmaceuticals, and Cipla over patent litigation related to Vyndamax, its treatment... Read More
India, April 28 -- Opera Limited (OPRA) reported a profit for its first quarter that Increases, from the same period last year The company's bottom line totaled $24.79 million, or $0.27 per share. Th... Read More
India, April 28 -- Ecolab Inc. (ECL) will host a conference call at 1:00 PM ET on April 28, 2026, to discuss Q1 26 earnings results. To access the live webcast, log on to https://investor.ecolab.com/... Read More
India, April 28 -- AvalonBay Communities (AVB) will host a conference call at 1:00 PM ET on April 28, 2026, to discuss Q1 26 earnings results. To access the live webcast, log on to https://investors.... Read More
India, April 27 -- Eastern Communications Co Ltd (600776.SS) announced a profit for its full year that Increased, from last year The company's earnings totaled RMB358.070 million, or RMB0.28508820 pe... Read More
India, April 27 -- Oruka Therapeutics, Inc. (ORKA) shares jumped 21.79 percent to $84.14, gaining $15.11 on Monday, after reporting strong interim Phase 2a clinical data for its lead drug candidate in... Read More